rs28647808

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_139027.6(ADAMTS13):​c.1852C>G​(p.Pro618Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0759 in 1,613,908 control chromosomes in the GnomAD database, including 5,313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.058 ( 353 hom., cov: 32)
Exomes 𝑓: 0.078 ( 4960 hom. )

Consequence

ADAMTS13
NM_139027.6 missense

Scores

5
5
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 6.56

Publications

46 publications found
Variant links:
Genes affected
ADAMTS13 (HGNC:1366): (ADAM metallopeptidase with thrombospondin type 1 motif 13) This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
ADAMTS13 Gene-Disease associations (from GenCC):
  • congenital thrombotic thrombocytopenic purpura
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041890144).
BP6
Variant 9-133440409-C-G is Benign according to our data. Variant chr9-133440409-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0877 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS13NM_139027.6 linkc.1852C>G p.Pro618Ala missense_variant Exon 16 of 29 ENST00000355699.7 NP_620596.2 Q76LX8-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS13ENST00000355699.7 linkc.1852C>G p.Pro618Ala missense_variant Exon 16 of 29 1 NM_139027.6 ENSP00000347927.2 Q76LX8-2

Frequencies

GnomAD3 genomes
AF:
0.0580
AC:
8825
AN:
152176
Hom.:
354
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0163
Gnomad AMI
AF:
0.0286
Gnomad AMR
AF:
0.0487
Gnomad ASJ
AF:
0.0760
Gnomad EAS
AF:
0.0199
Gnomad SAS
AF:
0.0228
Gnomad FIN
AF:
0.0617
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0896
Gnomad OTH
AF:
0.0630
GnomAD2 exomes
AF:
0.0605
AC:
15192
AN:
251016
AF XY:
0.0609
show subpopulations
Gnomad AFR exome
AF:
0.0153
Gnomad AMR exome
AF:
0.0327
Gnomad ASJ exome
AF:
0.0741
Gnomad EAS exome
AF:
0.0187
Gnomad FIN exome
AF:
0.0624
Gnomad NFE exome
AF:
0.0904
Gnomad OTH exome
AF:
0.0693
GnomAD4 exome
AF:
0.0778
AC:
113718
AN:
1461614
Hom.:
4960
Cov.:
36
AF XY:
0.0760
AC XY:
55271
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.0128
AC:
429
AN:
33476
American (AMR)
AF:
0.0341
AC:
1526
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0731
AC:
1910
AN:
26136
East Asian (EAS)
AF:
0.0232
AC:
923
AN:
39700
South Asian (SAS)
AF:
0.0225
AC:
1944
AN:
86258
European-Finnish (FIN)
AF:
0.0622
AC:
3306
AN:
53172
Middle Eastern (MID)
AF:
0.0602
AC:
347
AN:
5768
European-Non Finnish (NFE)
AF:
0.0891
AC:
99043
AN:
1111988
Other (OTH)
AF:
0.0710
AC:
4290
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
6308
12616
18925
25233
31541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3542
7084
10626
14168
17710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0579
AC:
8822
AN:
152294
Hom.:
353
Cov.:
32
AF XY:
0.0571
AC XY:
4254
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0162
AC:
675
AN:
41578
American (AMR)
AF:
0.0487
AC:
745
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0760
AC:
264
AN:
3472
East Asian (EAS)
AF:
0.0199
AC:
103
AN:
5172
South Asian (SAS)
AF:
0.0232
AC:
112
AN:
4826
European-Finnish (FIN)
AF:
0.0617
AC:
655
AN:
10618
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0896
AC:
6092
AN:
68010
Other (OTH)
AF:
0.0619
AC:
131
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
420
840
1261
1681
2101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0805
Hom.:
432
Bravo
AF:
0.0556
TwinsUK
AF:
0.0928
AC:
344
ALSPAC
AF:
0.0955
AC:
368
ESP6500AA
AF:
0.0179
AC:
79
ESP6500EA
AF:
0.0863
AC:
742
ExAC
AF:
0.0629
AC:
7635
Asia WGS
AF:
0.0380
AC:
130
AN:
3478
EpiCase
AF:
0.0863
EpiControl
AF:
0.0878

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16160007, 26139087, 26284228, 28939980, 23733198, 32531546, 23847193, 22768050, 25934476, 12614216) -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Upshaw-Schulman syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.020
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.38
T;T;.;.
Eigen
Pathogenic
0.73
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D;D;D;D
MetaRNN
Benign
0.0042
T;T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Pathogenic
2.9
M;.;M;.
PhyloP100
6.6
PrimateAI
Benign
0.43
T
PROVEAN
Pathogenic
-5.5
D;.;D;D
REVEL
Uncertain
0.30
Sift
Benign
0.050
D;.;D;T
Sift4G
Pathogenic
0.0
D;D;D;.
Polyphen
1.0
D;.;D;D
Vest4
0.59
MPC
0.64
ClinPred
0.010
T
GERP RS
5.1
Varity_R
0.27
gMVP
0.76
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28647808; hg19: chr9-136305530; COSMIC: COSV63020057; API